Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity
Top Cited Papers
Open Access
- 5 August 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 6 (8) , e1001036
- https://doi.org/10.1371/journal.ppat.1001036
Abstract
The bacterial pathogen Staphylococcus aureus seeds abscesses in host tissues to replicate at the center of these lesions, protected from host immune cells via a pseudocapsule. Using histochemical staining, we identified prothrombin and fibrin within abscesses and pseudocapsules. S. aureus secretes two clotting factors, coagulase (Coa) and von Willebrand factor binding protein (vWbp). We report here that Coa and vWbp together are required for the formation of abscesses. Coa and vWbp promote the non-proteolytic activation of prothrombin and cleavage of fibrinogen, reactions that are inhibited with specific antibody against each of these molecules. Coa and vWbp specific antibodies confer protection against abscess formation and S. aureus lethal bacteremia, suggesting that coagulases function as protective antigens for a staphylococcal vaccine. Clinical isolates of the human pathogen Staphylococcus aureus secrete coagulase (Coa), a polypeptide that binds to and activates prothrombin, thereby converting fibrinogen to fibrin and promoting clotting of plasma or blood. Another secreted coagulase, designated von-Willebrand factor binding protein (vWbp), catalyzes a similar reaction. Staphylococcal binding to fibrinogen or fibrin is an important attribute of disease pathogenesis, which leads to the formation of abscesses and bacterial persistence in host tissues. We report here that Coa and vWbp are essential for S. aureus strain Newman abscess formation and persistence in host tissues. Antibodies directed against Coa or vWbp prevent coagulase binding to prothrombin or fibrinogen and confer protection against challenge with S. aureus Newman or the methicillin-resistant S. aureus isolate USA300 LAC in mouse models of abscess formation or lethal sepsis. These results suggest that coagulases may be used as vaccine antigens to elicit antibodies that protect humans against S. aureus infections.Keywords
This publication has 57 references indexed in Scilit:
- Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in miceThe Journal of Experimental Medicine, 2010
- Molecular Characterization of the Interaction of Staphylococcal Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) ClfA and Fbl with FibrinogenJournal of Biological Chemistry, 2010
- Staphylococcus aureus synthesizes adenosine to escape host immune responsesThe Journal of Experimental Medicine, 2009
- Genetic requirements forStaphylococcus aureusabscess formation and persistence in host tissuesThe FASEB Journal, 2009
- Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombinProceedings of the National Academy of Sciences, 2009
- Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversificationProceedings of the National Academy of Sciences, 2008
- Genome Sequence of Staphylococcus aureus Strain Newman and Comparative Analysis of Staphylococcal Genomes: Polymorphism and Evolution of Two Major Pathogenicity IslandsJournal of Bacteriology, 2008
- Vaccine assembly from surface proteins ofStaphylococcus aureusProceedings of the National Academy of Sciences, 2006
- Immunogenicity and Protective Immunity against Bubonic Plague and Pneumonic Plague by Immunization of Mice with the Recombinant V10 Antigen, a Variant of LcrVInfection and Immunity, 2006
- A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis ModelInfection and Immunity, 2006